4//SEC Filing
Hopkinson Craig C. 4
Accession 0001520262-25-000010
CIK 0001520262other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:37 PM ET
Size
8.9 KB
Accession
0001520262-25-000010
Insider Transaction Report
Form 4
Alkermes plc.ALKS
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-11-03−5,000→ 40,104 totalExercise: $19.34Exp: 2031-02-22→ Ordinary Shares (5,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-11-03$19.34/sh+5,000$96,700→ 78,740 total - Sale
Ordinary Shares
2025-11-03$30.38/sh−9,000$273,442→ 69,740 total
Footnotes (4)
- [F1]This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- [F4]These options are fully vested in accordance with their terms.
Documents
Issuer
Alkermes plc.
CIK 0001520262
Entity typeother
Related Parties
1- filerCIK 0001730048
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 4:37 PM ET
- Size
- 8.9 KB